Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kaposi's sarcoma: introduction and overview.

J L Ziegler1

  • 1VA Medical Center, San Francisco, CA 94121.

Journal of Acquired Immune Deficiency Syndromes
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of Burkitt's Lymphoma.

Pediatric annals·2014
Same author

Kaposi's sarcoma, oncogenic viruses, and iron.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2001
Same author

Poverty and eosinophilia are risk factors for endomyocardial fibrosis (EMF) in Uganda.

Tropical medicine & international health : TM & IH·1999
Same author

Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.

AIDS (London, England)·1997
Same author

Geophagy: a vestige of palaeonutrition?

Tropical medicine & international health : TM & IH·1997
Same author

Echocardiographic diagnosis of heart disease in Uganda.

Tropical doctor·1996
Same journal

T lymphocyte homeostasis after HIV seroconversion.

Journal of acquired immune deficiency syndromes·1994
Same journal

Improved detection of HTLV-II antibody using a whole viral lysate-based EIA.

Journal of acquired immune deficiency syndromes·1994
Same journal

Changes in HIV risk behavior among French heterosexuals: patterns of sexual monogamy and condom use between 1988 and 1991.

Journal of acquired immune deficiency syndromes·1994
Same journal

HTLV-I-associated myelopathy in Venezuela.

Journal of acquired immune deficiency syndromes·1994
Same journal

Autoantibodies to nucleosomes in HIV-1-infected patients.

Journal of acquired immune deficiency syndromes·1994
Same journal

Seroprevalence of HIV-1 and syphilis antibodies in blood donors in Gonder, Ethiopia, 1989-1993.

Journal of acquired immune deficiency syndromes·1994
See all related articles

Kaposi sarcoma (KS) serves as a cancer development model, appearing on the skin with a preneoplastic stage. Its varied clinical behavior is influenced by geographic, environmental, genetic, and acquired factors, prompting further research.

Area of Science:

  • Oncology
  • Dermatology
  • Epidemiology

Background:

  • Kaposi sarcoma (KS) is a significant model for understanding cancer development.
  • KS is observable in the skin and has a recognizable preneoplastic counterpart.
  • The etiology of KS is multifactorial, involving geographic, environmental, genetic, and acquired conditions.

Purpose of the Study:

  • To explore Kaposi sarcoma as a paradigm for cancer development.
  • To investigate the varied clinical manifestations and natural history of KS.
  • To identify etiologic covariants and develop hypothetical models for KS research.

Main Methods:

  • Histologic examination for consistent tumor appearance.
  • Clinical observation of varied manifestations and natural history.

Related Experiment Videos

  • Epidemiologic, clinical, and biologic studies to investigate etiologic factors.

    • Main Results:

    • KS exhibits a consistent histologic appearance despite diverse clinical presentations.
    • Tumor and host determinants contribute to the varied natural history of KS.
    • The multifactorial nature of KS development is supported by its association with various conditions.

    Conclusions:

    • Kaposi sarcoma is a valuable model for cancer research due to its observable nature and preneoplastic stages.
    • Understanding the interplay of tumor and host factors is crucial for explaining KS variability.
    • Further intensive research is warranted to elucidate KS etiologic covariants and refine predictive models.